loadpatents
Patent applications and USPTO patent grants for Petri; Andreas.The latest application filed is for "therapeutic targeting of a microrna to treat duchenne muscular dystrophy".
Patent | Date |
---|---|
Therapeutic Targeting of a microRNA to Treat Duchenne Muscular Dystrophy App 20220213477 - Naar; Anders M. ;   et al. | 2022-07-07 |
Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy Grant 11,236,336 - Naar , et al. February 1, 2 | 2022-02-01 |
Antisense Oligomers Targeting Pcsk9 App 20220025376 - ALB K; Nanna ;   et al. | 2022-01-27 |
Antisense oligomers targeting PCSK9 Grant 11,091,764 - Alb.ae butted.k , et al. August 17, 2 | 2021-08-17 |
Inhibitors Of Micro-rna 22 App 20210017521 - PANDOLFI; Pier Paolo ;   et al. | 2021-01-21 |
Therapeutic Targeting of a microRNA to Treat Duchenne Muscular Dystrophy App 20200362342 - Naar; Anders M. ;   et al. | 2020-11-19 |
Antisense oligomers targeting HOXB-AS3 long non-coding RNA Grant 10,787,665 - Garzon , et al. September 29, 2 | 2020-09-29 |
Antisense Oligomers Targeting Pcsk9 App 20200248186 - Kind Code | 2020-08-06 |
Ketoreductases Grant 10,724,008 - Schmiedel , et al. | 2020-07-28 |
Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy Grant 10,626,395 - Naar , et al. | 2020-04-21 |
Targeting Human Satellite Ii (hsatii) App 20200017856 - Ting; David T. ;   et al. | 2020-01-16 |
Antisense oligomers targeting PCSK9 Grant 10,443,058 - Alb.ae butted.k , et al. Oc | 2019-10-15 |
Therapeutic Targeting of a microRNA to Treat Duchenne Muscular Dystrophy App 20190270993 - Naar; Anders M. ;   et al. | 2019-09-05 |
Antisense Oligomers Targeting Hoxb-as3 Long Non-coding Rna App 20190256848 - GARZON; Ramiro ;   et al. | 2019-08-22 |
Methods of treatment using antisense oligomers and conjugates targeting PCSK9 Grant 10,385,342 - Alb.ae butted.k , et al. A | 2019-08-20 |
Manufacture of antisense oligomers and conjugates targeting PCSK9 Grant 10,370,668 - Alb.ae butted.k , et al. | 2019-08-06 |
Targeting human satellite II (HSATII) Grant 10,301,624 - Ting , et al. | 2019-05-28 |
Ketoreductases App 20190062714 - Schmiedel; Ramona ;   et al. | 2019-02-28 |
Manufacture of Antisense Oligomers and Conjugates Targeting PCSK9 App 20180312846 - ALB K; Nanna ;   et al. | 2018-11-01 |
Methods of Treatment Using Antisense Oligomers and Conjugates Targeting PCSK9 App 20180312847 - ALB K; Nanna ;   et al. | 2018-11-01 |
Ketoreductases Grant 10,093,905 - Schmiedel , et al. October 9, 2 | 2018-10-09 |
Antisense Oligomers And Conjugates Targeting Pcsk9 App 20180216116 - Albaek; Nanna ;   et al. | 2018-08-02 |
Oligonucleotide conjugates Grant 9,879,265 - Alb.ae butted.k , et al. January 30, 2 | 2018-01-30 |
Ketoreductases App 20170218345 - Schmiedel; Ramona ;   et al. | 2017-08-03 |
Oligonucleotide Conjugates App 20160138025 - ALB K; Nanna ;   et al. | 2016-05-19 |
Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferon Grant 9,034,837 - Hildebrandt-Eriksen , et al. May 19, 2 | 2015-05-19 |
Lipolytic enzyme variants Grant 8,679,774 - Bojsen , et al. March 25, 2 | 2014-03-25 |
Pharmaceutical Compositions for Treatment of HCV Patients that are Poor-Responders to Interferon App 20100330035 - HILDEBRANDT-ERIKSEN; Elisabeth S. ;   et al. | 2010-12-30 |
Lipolytic enzyme variants Grant 7,851,176 - Bojsen , et al. December 14, 2 | 2010-12-14 |
Lipolytic Enzyme Variants App 20100291262 - Bojsen; Kirsten ;   et al. | 2010-11-18 |
Lipolytic enzyme variants Grant 7,632,669 - Bojsen , et al. December 15, 2 | 2009-12-15 |
Lipolytic Enzyme Variants App 20090047384 - Bojsen; Kirsten ;   et al. | 2009-02-19 |
Lipolytic Enzyme Variants App 20080131951 - Bojsen; Kirsten ;   et al. | 2008-06-05 |
Lipolytic enzyme variants Grant 7,312,062 - Bojsen , et al. December 25, 2 | 2007-12-25 |
Lipolytic enzyme variants App 20050059130 - Bojsen, Kirsten ;   et al. | 2005-03-17 |
Helical liquid crystalline element which produces linear polarized light Grant 5,301,045 - Miller , et al. April 5, 1 | 1994-04-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.